Back
Abbott Laboratories 10K Form
Sell
35
ABT
Abbott Laboratories
Last Price:
98.73
Seasonality Move:
4.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-05 | 10Q | ABT/Abbott Laboratories Quarterly |
| 2020-11-04 | 10Q | ABT/Abbott Laboratories Quarterly |
| 2020-07-29 | 10Q | ABT/Abbott Laboratories Quarterly |
| 2020-04-29 | 10Q | ABT/Abbott Laboratories Quarterly |
| 2020-02-21 | 10K | ABT/Abbott Laboratories Annual |
| 2019-10-31 | 10Q | ABT/Abbott Laboratories Quarterly |
Receive ABT News And Ratings
See the #1 stock for the next 7 days that we like better than ABT
ABT Financial Statistics
Sales & Book Value
| Annual Sales: | $43.65B |
|---|---|
| Cash Flow: | $1.72B |
| Price / Cash Flow: | 22.23 |
| Annual Sales: | $21.11 |
| Price / Book: | 4.66 |
Profitability
| EPS (TTM): | 3.91000 |
|---|---|
| Net Income (TTM): | $6.93B |
| Gross Margin: | $24.51B |
| Return on Equity: | 19.25% |
| Return on Assets: | 9.35% |
Abbott Laboratories Earnings Forecast
Key Abbott Laboratories Financial Ratios
- The Gross Profit Margin over the past 39 years for ABT is 56.15%.
- The Selling, General & Administrative Expenses for ABT have been equal to 25.77% of Gross Profit Margin.
- The Research & Development expenses have been 6.62% of Revenue.
- The Interest Expense is 8.05% of Operating Income.
- The Net Earning history of ABT is 15.88% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 29 years.
Abbott Laboratories Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Medical Devices |
| Sector: | Healthcare |
| Current Symbol: | ABT |
| CUSIP: | 002824 |
| Website: | abbottinvestor.com |
Debt
| Debt-to-Equity Ratio: | 0.46 |
|---|---|
| Current Ratio: | 1.63 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 25.15 |
|---|---|
| Forward P/E Ratio: | 20.31 |
ABT Technical Analysis vs Fundamental Analysis
Sell
35
Abbott Laboratories (ABT)
is a Sell
Is Abbott Laboratories a Buy or a Sell?
-
Abbott Laboratories stock is rated a Sell
The current Abbott Laboratories [ABT] share price is $98.33. The Score for ABT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.